Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model
Thomas M. Zollner(Bayer (Germany)), Wolf‐Henning Boehncke(University Hospital of Geneva), Maurizio Podda(Goethe University Frankfurt), Roland Kaufmann(Robert Koch Institute), Christine Pien(Millennium Engineering and Integration (United States)), Peter J. Elliott(Advanced Process Combinatorics (United States))
Cited by 94
Related Papers
Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines
|European Journal of Cancer|2019|589
Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition
|BMC Cancer|2012|561
Psoriasis: a possible risk factor for development of coronary artery calcification
|British Journal of Dermatology|2006|376
Nicotinamide Improves Aspects of Healthspan, but Not Lifespan, in Mice
|Cell Metabolism|2018|332
European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022
|European Journal of Cancer|2022|320